A study on the seroprevalence of cytomegalovirus infection in patients with coronary artery disease in a tertiary care hospital

---

Original Article

Author Details : Prabhu Vairavel*, C.P. Ramani

Volume : 4, Issue : 4, Year : 2018

Article Page : 272-275

https://doi.org/10.18231/2581-4761.2018.0058

Suggest article by email

Get Permission

---

Abstract

Introduction: Coronary artery disease (CAD) is a leading cause of death in developing and developed countries. Infectious etiology is also suspected to be a significant risk factor in these cases. CMV is a beta herpes virus. Once infected, the person carries the virus for life.80% adults show CMV specific antibodies in their serum indicating the high prevalence of CMV infection.
Aim: To know the seroprevalence of CMV infection in patients with CAD
Materials and Methods: Clinically stable patients undergoing coronary angiography because of symptoms suspected of CAD were included in the study. The samples were tested for specific anti-CMV IgG antibodies by ELISA
Results: Of 150 patients, 86 % had detectable quantities of anti-CMV IgG antibodies in their serum. 15 patients (10%) were found to be ‘borderline positive,’ and the antibody index was between 0.9 to 1.1. 6 patients (4%) did not have detectable quantities of anti-CMV IgG antibodies in their serum. Prevalence of CAD was 100% in the study group.
Conclusion: Cytomegalovirus is an essential cause of atherosclerosis due to the infectious burden. In the study population, 86% of the patients showed elevated levels of anti-CMV IgG antibody. So, there is an association between CMV infection and coronary artery disease.

Keywords: Coronary artery diseases, Cytomegalovirus, Infection.

How to cite : Vairavel P , Ramani C , A study on the seroprevalence of cytomegalovirus infection in patients with coronary artery disease in a tertiary care hospital. IP Int J Med Microbiol Trop Dis 2018;4(4):272-275

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.